The record
Written from the 1 report below. Nothing here is unsourced.
- Artificial intelligence startup Anthropic has opened a physical laboratory in the San Francisco Bay Area to conduct hands-on biological experiments.
- The company aims to use its Claude AI to automate laboratory processes and develop treatments for rare or 'undruggable' diseases that the pharmaceutical industry often neglects.
- While the startup plans to maintain some in-house capabilities, it will continue to collaborate with external partners and provide AI tools to major pharmaceutical companies.
What to watch next
- Progression of Anthropic's drug development programs and potential movement into clinical trials.
- Management of data privacy concerns from pharmaceutical partners using Anthropic's AI services.
- Impact of in-house laboratory automation on the speed of drug discovery.
Who said what3
Only words found exactly in the article are shown, attributed and linked to the line they came from.
Eric Kauderer-Abrams
Anthropic's head of life sciences
3 quotes · 1 outlet
“We believe that to do biology, the final test is still and will be for a while in real lab work”
In the article
…for rare diseases, and its biology work has gone beyond "in silico" or computer evaluations. In a Reuters interview on Tuesday, Anthropic's head of life sciences, Eric Kauderer-Abrams, confirmed the startup's wet lab. " We believe that to do biology, the final test is still and will be for a while in real lab work ," he said. "We absolutely are doing that today, and I would describe our approach as being typical of what you would see in most biotech companies, where there's some amount of that that we're doing in our own…
“By far, we see the biggest opportunity for that in the life sciences, and that is motivating everything that we’re doing.”
In the article
…few years before a cure came about, he said in a recent essay. Kauderer-Abrams echoed the sentiment. “The mission of the company is to develop powerful AI in such a way that benefits the world,” Kauderer-Abrams said. “ By far, we see the biggest opportunity for that in the life sciences, and that is motivating everything that we’re doing. ” BALANCING AMBITION WITH FEARS OF CATASTROPHE Like other biotech companies, Anthropic is embracing physical automation, said the two people, who spoke on condition of anonymity. The startup wants to push how its Claude…
Coverage1
All filed from India
Named United States · Bristol Myers Squibb · Coefficient Bio · Genentech · Novo Nordisk · San Francisco Bay Area · Alphabet · Anthropic · Dario Amodei · Eric Kauderer-Abrams · Isomorphic Labs · Vas Narasimhan
The 1 report is listed beside the record.
Ask this story
Answers cite the reports above, or say they can't.